Sarah Y Garron-Arias

Sarah Y Garron-Arias

Auto-generated profile, based on publicly available information

Sarah Y Garron-Arias

Instituto Médico ENERI, Clinica La Sagrada Familia , Av. del Libertador 6647, Cdad, Autónoma de Buenos Aires, Argentina

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2025 in European Heart Journal - Digital Health
Verified
Journal Article
Open access
RPRosana Poggio
Rosana Poggio
GRGaston A Rodriguez-Granillo
Gaston A Rodriguez-Granillo
FLFlorencia De Lillo
Florencia De Lillo
ARAlejandra Bibiana Rubilar
Alejandra Bibiana Rubilar
SGSarah Y Garron-Arias
Sarah Y Garron-Arias
SMSantiago Miriuka
Santiago Miriuka
Aims: Whole blood RNA expression is modulated in response to signals from tissues, including the vessel wall. The primary objective of this study was to explore the ability of whole blood transcriptomes, analysed using artificial intelligence (AI), to predict coronary artery calcifications (CAC). Methods and results: A total of 196 subjects [men aged 40–70 years and women aged 50–70 years without known cardiovascular disease (CVD)] were non-consecutively enrolled for CAC assessment via chest computed tomography. Whole blood RNA was isolated and sequenced. Different AI models were trained using clinical and transcriptomic variables as distinctive features to identify the presence of CAC (Agatston score >0). Finally, we compared the predictive performance of these models. The prevalence of CAC was 43.9%. The combined AI model, incorporating transcriptome data along with age, sex, body mass index, smoking status, diabetes, and hypercholesterolaemia, achieved an area under the curve (AUC) of 0.92 (95% CI, 0.88–0.95) for predicting the presence of CAC, with a sensitivity of 92%, specificity of 80%, positive predictive value of 81%, negative predictive value of 91%, and an overall accuracy of 86%. The combined AI model demonstrated significantly improved discrimination compared with the transcriptomic model (AUC 0.79; P = 0.009), the clinical variables model (AUC 0.72; P < 0.001), and the CVD risk model (AUC 0.68; P < 0.001). Conclusion: In this pilot study, an AI model integrating whole blood transcriptome data with clinical risk factors demonstrated the ability to predict CAC, providing incremental value over clinical models. Further studies are needed to achieve more robust validation.